Literature DB >> 7955524

Characterization of the virulence of Mycobacterium avium complex (MAC) isolates in mice.

J Pedrosa1, M Flórido, Z M Kunze, A G Castro, F Portaels, J McFadden, M T Silva, R Appelberg.   

Abstract

The virulence of different isolates of MAC was studied in naturally susceptible BALB/c mice. In preliminary experiments, MAC bacteria forming smooth transparent colonies on solid media (SmT variants) were found to be virulent for BALB/c mice, causing progressive infection; smooth opaque (SmOp) were generally avirulent, being slowly eliminated from the infected organs; and rough (Rg) variants were either avirulent or as virulent as SmT variants. We chose to compare the virulence of different isolates of MAC of different origins, studying only the SmT morphotype. Strains of MAC isolated from naturally infected animals were those that most consistently caused progressive infections. AIDS patients-derived isolates were of intermediate virulence or devoid of virulence in mice. The environmental strains were eliminated from mice or did not proliferate. Strains of MAC isolated from individuals who were not infected by HIV varied in virulence from completely avirulent to highly virulent. There was no close correlation between virulence and restriction fragment length polymorphism (RFLP) type, although all highly virulent strains were of the A/I type. There was also no correlation between virulence analysed in vivo and the ability to grow in cultured macrophages.

Entities:  

Mesh:

Year:  1994        PMID: 7955524      PMCID: PMC1534398          DOI: 10.1111/j.1365-2249.1994.tb06127.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  22 in total

Review 1.  Epidemiological and genetic markers, virulence factors and intracellular growth of Mycobacterium avium in AIDS.

Authors:  J J McFadden; Z M Kunze; F Portaels; V Labrousse; N Rastogi
Journal:  Res Microbiol       Date:  1992-05       Impact factor: 3.992

Review 2.  Proposed minimal standards for the genus Mycobacterium and for description of new slowly growing Mycobacterium species.

Authors:  V V Lévy-Frébault; F Portaels
Journal:  Int J Syst Bacteriol       Date:  1992-04

3.  Pathogenicity of transparent, opaque, and rough variants of Mycobacterium avium in chickens and mice.

Authors:  W B Schaefer; C L Davis; M L Cohn
Journal:  Am Rev Respir Dis       Date:  1970-10

4.  Relationship of colonial morphology to virulence for chickens of Mycobacterium avium and the nonphotochromogens.

Authors:  J M Moehring; M R Solotorovsky
Journal:  Am Rev Respir Dis       Date:  1965-11

5.  Induction and expression of protective T cells during Mycobacterium avium infections in mice.

Authors:  R Appelberg; J Pedrosa
Journal:  Clin Exp Immunol       Date:  1992-03       Impact factor: 4.330

6.  In vitro effects of interleukin-4 on interferon-gamma-induced macrophage activation.

Authors:  R Appelberg; I M Orme; M I Pinto de Sousa; M T Silva
Journal:  Immunology       Date:  1992-08       Impact factor: 7.397

7.  In vivo depletion of natural killer cell activity leads to enhanced multiplication of Mycobacterium avium complex in mice.

Authors:  K V Harshan; P R Gangadharam
Journal:  Infect Immun       Date:  1991-08       Impact factor: 3.441

8.  Survival of patients with acquired immune deficiency syndrome and disseminated Mycobacterium avium complex infection with and without antimycobacterial chemotherapy.

Authors:  C R Horsburgh; J A Havlik; D A Ellis; E Kennedy; S A Fann; R E Dubois; S E Thompson
Journal:  Am Rev Respir Dis       Date:  1991-09

9.  Effector mechanisms involved in cytokine-mediated bacteriostasis of Mycobacterium avium infections in murine macrophages.

Authors:  R Appelberg; I M Orme
Journal:  Immunology       Date:  1993-11       Impact factor: 7.397

10.  Role of gamma interferon and tumor necrosis factor alpha during T-cell-independent and -dependent phases of Mycobacterium avium infection.

Authors:  R Appelberg; A G Castro; J Pedrosa; R A Silva; I M Orme; P Minóprio
Journal:  Infect Immun       Date:  1994-09       Impact factor: 3.441

View more
  37 in total

1.  A genetic mechanism for deletion of the ser2 gene cluster and formation of rough morphological variants of Mycobacterium avium.

Authors:  T M Eckstein; J M Inamine; M L Lambert; J T Belisle
Journal:  J Bacteriol       Date:  2000-11       Impact factor: 3.490

2.  Evidence for a reduced chemokine response in the lungs of beige mice infected with Mycobacterium avium.

Authors:  M Florido; R Appelberg; I M Orme; A M Cooper
Journal:  Immunology       Date:  1997-04       Impact factor: 7.397

3.  The phagosomal environment protects virulent Mycobacterium avium from killing and destruction by clarithromycin.

Authors:  C Fréhel; C Offredo; C de Chastellier
Journal:  Infect Immun       Date:  1997-07       Impact factor: 3.441

4.  Tumour necrosis factor-alpha (TNF-alpha) in the host resistance to mycobacteria of distinct virulence.

Authors:  R Appelberg; A Sarmento; A G Castro
Journal:  Clin Exp Immunol       Date:  1995-08       Impact factor: 4.330

5.  Virulent Mycobacterium fortuitum restricts NO production by a gamma interferon-activated J774 cell line and phagosome-lysosome fusion.

Authors:  Tânia Regina Marques Da Silva; Juliana Ribeiro De Freitas; Queilan Chagas Silva; Cláudio Pereira Figueira; Eliana Roxo; Sylvia Cardoso Leão; Luiz Antônio Rodrigues De Freitas; Patrícia Sampaio Tavares Veras
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

6.  Identification and recombinant expression of a Mycobacterium avium rhamnosyltransferase gene (rtfA) involved in glycopeptidolipid biosynthesis.

Authors:  T M Eckstein; F S Silbaq; D Chatterjee; N J Kelly; P J Brennan; J T Belisle
Journal:  J Bacteriol       Date:  1998-11       Impact factor: 3.490

7.  Host genetics in granuloma formation: human-like lung pathology in mice with reciprocal genetic susceptibility to M. tuberculosis and M. avium.

Authors:  Elena Kondratieva; Nadya Logunova; Konstantin Majorov; Mikhail Averbakh; Alexander Apt
Journal:  PLoS One       Date:  2010-05-06       Impact factor: 3.240

8.  Relationship between virulence of Mycobacterium avium strains and induction of tumor necrosis factor alpha production in infected mice and in in vitro-cultured mouse macrophages.

Authors:  A M Sarmento; R Appelberg
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

9.  The relative impact of bacterial virulence and host genetic background on cytokine expression during Mycobacterium avium infection of mice.

Authors:  A G Castro; P Minóprio; R Appelberg
Journal:  Immunology       Date:  1995-08       Impact factor: 7.397

10.  CD40 is required for the optimal induction of protective immunity to Mycobacterium avium.

Authors:  Manuela Flórido; Ana Sofia Gonçalves; M Salomé Gomes; Rui Appelberg
Journal:  Immunology       Date:  2004-03       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.